2026 NPPES data Dermatopathology Physician NPI 1740207737 MD
Verify on CMS →

CARY FEIBLEMAN, MD

Dermatopathology Physician in SAN LEANDRO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
572
Medicare Part D claims · 290 beneficiaries · Dermatopathology Physician avg: 650
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$2.0K
83 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CARY FEIBLEMAN, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 572 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
572
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CARY FEIBLEMAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

CARY FEIBLEMAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CARY FEIBLEMAN, MD?

Below national average

NPI registry status

Active

Issued 07/16/2006

NPI 1740207737

Primary specialty

Dermatopathology Physician

Niche

570 US NPIs in this specialty

Medicare Part D claims

572 12% vs specialty avg

2023 prescription claims

Specialty avg: 650

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Dermatopathology Physician compares to other specialties among California providers

California providers

Dermatopathology Physician share within California

1. Dermatopathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatopathology Physician share within California

Medicare quality performance — MIPS

CARY FEIBLEMAN, MD's 2023 MIPS final score plotted against the Dermatopathology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatopathology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Dermatopathology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CARY FEIBLEMAN, MD appears in the CMS NPPES registry as a Dermatopathology Physician provider holding MD credentials at 13847 E 14TH ST STE 218, SAN LEANDRO, CA, 94578, with a listed phone of (510) 483-0312. NPI 1740207737 was issued on 07/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FEIBLEMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 572 prescription claims written by this provider, covering 290 Medicare beneficiaries and totaling roughly $222K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Dermatopathology Physician is a narrow specialty nationwide, with 570 enrolled providers across 48 states and an average of 650 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13847 E 14TH ST STE 218
SAN LEANDRO, CA 94578

Provider Details

NPI 1740207737
Specialty Dermatopathology Physician
Credentials MD
Gender Male
NPI Issued 07/16/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where CARY FEIBLEMAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CSI MEDICAL GROUP
SAN LEANDRO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CARY FEIBLEMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.0K

Largest payer

Janssen Biotech, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to CARY FEIBLEMAN, MD. To verify CARY FEIBLEMAN, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

CARY FEIBLEMAN, MD — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 572 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

572
Total Claims
$222K
Total Drug Cost
290
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
645
Total Day Supply
16,041
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$189K
Generic Drug Cost
$33K
Antibiotic Claims
78

Patient Demographics

Average Patient Age
76.7 years
Avg HCC Risk Score
1.07
Gender Split
49% female / 51% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CARY FEIBLEMAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Betamethasone Dipropionate
60
Triamcinolone Acetonide
60
Doxycycline Hyclate
48
Ketoconazole
46
Clobetasol Propionate
44
Mupirocin
39
Fluorouracil
32
Dupixent Pen
Dupilumab
19
Fluocinonide
15
Imiquimod
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatopathology Physician Overview

How CARY FEIBLEMAN, MD fits within the Dermatopathology Physician landscape nationally.

570
Dermatopathology Physician Providers in US
48
States with Dermatopathology Physician
650
Avg Claims per Provider

CARY FEIBLEMAN, MD's 572 claims are below the specialty average of 650.

Nearby Dermatopathology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FEIBLEMAN.

Compare Dermatopathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CARY FEIBLEMAN, MD's specialty?
CARY FEIBLEMAN, MD specializes in Dermatopathology Physician and practices in SAN LEANDRO, California. Credentials: MD.
How much does CARY FEIBLEMAN, MD prescribe under Medicare Part D?
In 2023, CARY FEIBLEMAN, MD wrote 572 Medicare Part D claims totaling $222K in drug costs for 290 beneficiaries.
What is CARY FEIBLEMAN, MD's Medicare quality score?
CARY FEIBLEMAN, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CARY FEIBLEMAN, MD located?
CARY FEIBLEMAN, MD is located at 13847 E 14TH ST STE 218, SAN LEANDRO, CA, 94578. Phone: (510) 483-0312.
What is CARY FEIBLEMAN, MD's NPI number?
CARY FEIBLEMAN, MD's National Provider Identifier (NPI) is 1740207737, issued on 07/16/2006.
Does CARY FEIBLEMAN, MD prescribe more brand-name or generic drugs?
CARY FEIBLEMAN, MD's prescribing is 7% brand-name and 93% generic drugs by claim count, with $189K in brand drug costs.
How many Dermatopathology Physician providers are there in the US?
There are 570 Dermatopathology Physician providers across 48 states in the US. The average Dermatopathology Physician provider writes 650 Medicare Part D claims per year.
What drugs does CARY FEIBLEMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, CARY FEIBLEMAN, MD's most frequently prescribed drugs include Betamethasone Dipropionate, Triamcinolone Acetonide, Doxycycline Hyclate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CARY FEIBLEMAN, MD accept Medicare?
CARY FEIBLEMAN, MD appears in CMS Medicare data with 572 Part D claims and 290 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CARY FEIBLEMAN, MD's credentials?
CARY FEIBLEMAN, MD's NPI is 1740207737 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology